Par Pharmaceutical launched the generic equivalent of 2.25 MG strength of Mirapex ER® (pramipexole dihydrochloride) extended-release tablets. The Par item will be added to the OneStop program in the A*- slot, with visibility in McKesson Connect on Tuesday, November 24, 2015. Estimated brand sales of Mirapex ER®are $6M.
Brand Item:
| Item # |
NDC |
Description |
| 1168558 |
00597028630 |
PRAMIPEXOLE ER TAB 2.25 MG 30 |
There will not be ASAP and ASAP+ for this launch.
| Product Launch Information – OneStop Add
|
| Bx Name |
Mirapex ER 2.25mg |
| Bx Supplier |
BOEHRINGER INGELHEIM |
| Generic Name |
pramipexole dihydrochloride |
| Generic Description |
pramipexole dihydrochloride tab 2.25mg 30 |
| Indication |
283620-DOPAMINE RECEPTOR AGONISTS. Indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease. |
| FDA Approval Date |
2/6/2014 |
| Launch Reason |
N/A |
| FDA Launch Exclusivity |
Yes |
| Number of Players |
1 |
| US Brand Sales |
$6M |
To order, please use the following item numbers:
| Item # |
Supplier Name |
NDC |
Description |
OS ADD |
| 3427069 |
PAR PHARMACEUTICAL INC |
10370030511 |
PRAMIPEXOLE ER TAB 2.25 MG 30 |
11/24/2015 |
For questions please contact ISManagement@McKesson.com.